至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Structural characterization of SARS-CoV-2 dimeric ORF9b reveals potential fold-switching trigger mechanism

Sci China Life Sci. 2022-09; 
Xiyue Jin, Xue Sun, Yan Chai, Yu Bai, Ying Li, Tianjiao Hao, Jianxun Qi, Hao Song, Catherine C L Wong, George F Gao
Products/Services Used Details Operation
Plasmid DNA Preparation … coli at GenScript Company. The plasmid was transformed into E. coli strain BL21 (DE3) and then expressed (IPTG, 1 mmol L −1 final concentration) at 16 C for 18 h in Luria Broth Base … Get A Quote

摘要

The constant emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants indicates the evolution and adaptation of the virus. Enhanced innate immune evasion through increased expression of viral antagonist proteins, including ORF9b, contributes to the improved transmission of the Alpha variant; hence, more attention should be paid to these viral proteins. ORF9b is an accessory protein that suppresses innate immunity via a monomer conformation by binding to Tom70. Here, we solved the dimeric structure of SARS-CoV-2 ORF9b with a long hydrophobic tunnel containing a lipid molecule that is crucial for the dimeric conformation and determined the specific lipid ligands as monoglycerides by cond... More

关键词

ORF9b, SARS-CoV-2, fold switch, immune escape, lipid binding, membrane association, viral antagonist